![Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes](https://www.mdpi.com/diabetology/diabetology-03-00007/article_deploy/html/images/diabetology-03-00007-g001.png)
Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
![Frontiers | Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement Frontiers | Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement](https://www.frontiersin.org/files/Articles/859638/fendo-13-859638-HTML-r1/image_m/fendo-13-859638-g001.jpg)
Frontiers | Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement
![CRISPR, ViaCyte begin dosing in phase 1 trial of gene-edited therapy for type 1 diabetes | Seeking Alpha CRISPR, ViaCyte begin dosing in phase 1 trial of gene-edited therapy for type 1 diabetes | Seeking Alpha](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/958260280/image_958260280.jpg?io=getty-c-crop-4-3)
CRISPR, ViaCyte begin dosing in phase 1 trial of gene-edited therapy for type 1 diabetes | Seeking Alpha
![Frontiers | Functional Genomics in Pancreatic β Cells: Recent Advances in Gene Deletion and Genome Editing Technologies for Diabetes Research Frontiers | Functional Genomics in Pancreatic β Cells: Recent Advances in Gene Deletion and Genome Editing Technologies for Diabetes Research](https://www.frontiersin.org/files/MyHome%20Article%20Library/576632/576632_Thumb_400.jpg)
Frontiers | Functional Genomics in Pancreatic β Cells: Recent Advances in Gene Deletion and Genome Editing Technologies for Diabetes Research
![Type 1 diabetes risk genes mediate pancreatic beta cell survival in response to proinflammatory cytokines - ScienceDirect Type 1 diabetes risk genes mediate pancreatic beta cell survival in response to proinflammatory cytokines - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666979X22001677-fx1.jpg)
Type 1 diabetes risk genes mediate pancreatic beta cell survival in response to proinflammatory cytokines - ScienceDirect
CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review | PLOS ONE
![Frontiers | Functional Genomics in Pancreatic β Cells: Recent Advances in Gene Deletion and Genome Editing Technologies for Diabetes Research Frontiers | Functional Genomics in Pancreatic β Cells: Recent Advances in Gene Deletion and Genome Editing Technologies for Diabetes Research](https://www.frontiersin.org/files/Articles/576632/fendo-11-576632-HTML-r1/image_m/fendo-11-576632-g002.jpg)
Frontiers | Functional Genomics in Pancreatic β Cells: Recent Advances in Gene Deletion and Genome Editing Technologies for Diabetes Research
![Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes | Nature Metabolism Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes | Nature Metabolism](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs42255-020-0254-1/MediaObjects/42255_2020_254_Fig1_HTML.png)
Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes | Nature Metabolism
![Looking into the possibilities of cure of the type 2 diabetes mellitus by nanoparticle-based RNAi and CRISPR-Cas9 system: A review - ScienceDirect Looking into the possibilities of cure of the type 2 diabetes mellitus by nanoparticle-based RNAi and CRISPR-Cas9 system: A review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1773224721005104-gr4.jpg)
Looking into the possibilities of cure of the type 2 diabetes mellitus by nanoparticle-based RNAi and CRISPR-Cas9 system: A review - ScienceDirect
![B.C. researchers launching clinical trial for first genetically engineered stem cell-based therapy for type 1 diabetes B.C. researchers launching clinical trial for first genetically engineered stem cell-based therapy for type 1 diabetes](https://news.ubc.ca/wp-content/uploads/2022/05/Insulin-pens_Unsplash-scaled.jpg)